Normal Tissue Perfusion Changes During Everolimus Treatment: Preliminary Results from a Functional Vascular Study Abstract #1007

Introduction: Everolimus (E) acts on cancer progression, even inhibiting tumor angiogenesis. Both tumor vasculature and a normal one could undergo everolimus effect.
Aim(s): To analyze short-term changes in vascular function caused by E in patients with pNETs.
Materials and methods: In four patients with advanced E-treated pNETs, at baseline (B), after one month (T1) and 2 months (T2), we evaluated: central blood pressures (CBP), Augmentation Index (AIx) and Pulse Wave Velocity (PWV) using Sphygmocor as markers of arterial stiffness and arteriolar resistance, microcircular perfusion flow (PF) and vasodilatation response to ischemia (VDRI) using Laser-Doppler Flowmetry as a marker of endothelial function.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Sara Cingarlini

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result